Silo Pharma (SILO) news
Recent news
Payward-Saldo deal seen closing in 2027
The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
AInvest Wire · 8h agoSilo Pharma - Enters asset purchase agreement with Norsight Consulting on Oct 1, 2026 - SEC filing
AInvest Wire · Oct 2, 2026Silo Pharma, Inc.: Silo Pharma’s QwikAgents expands AI agent platform with Nvidia model support, new runtime flexibility
AInvest Wire · Sep 30, 2026Silo Pharma, Inc.: Silo Pharma's QwikAgents expands AI agent platform with Nvidia model support, new runtime flexibility
Silo Pharma, Inc. has announced that its subsidiary, QwikAgents, has joined the NVIDIA Developer Program to enhance its AI agent platform. This move is part of a broader industry trend where AI and automation are transitioning from supplementary tools to essential components of business operations…
AInvest Wire · Sep 30, 2026Silo Pharma: selling shareholders offer on resale basis 1.9 mln shares of Silo Pharma common stock - SEC filing
Silo Pharma has announced that selling shareholders are offering 1.9 million shares of its common stock on a resale basis, as disclosed in a recent SEC filing [1]. The offering is part of a registered resale of previously issued shares and does not involve the company issuing new stock or receiving…
AInvest Wire · Jul 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.